{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:40:21Z","timestamp":1792507221319,"version":"4.5.0"},"reference-count":25,"publisher":"Media Sphere Publishing House","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["S.S. Korsakov J. Neuro. Psych."],"published-print":{"date-parts":[[2026,10,20]]},"abstract":"<jats:p>Objective. To compare the efficacy and tolerability of combination therapy with clozapine and atypical antipsychotics for patients with treatment-resistant schizophrenia, comorbid with chemical addictions. Material and methods. A clinical study was conducted from 2018 to 2026 in various psychiatric departments in the North-Western, Siberian, and Ural regions of the Russian Federation. The study included a total of 470 male and female participants diagnosed with therapeutically resistant paranoid schizophrenia, comprising individuals with and without concomitant chemical addictions: n=80 without addictions; n=390 with unrelated chemical addictions (opioid, cannabinoid, psychostimulant, and ethanol dependence). Participants were randomly allocated into six treatment groups receiving distinct combinations of medications: clozapine with cariprazine (n=84), lurasidone (n=84), aripiprazole (n=78), risperidone (n=84), olanzapine (n=70), or brexpiprazole (n=70). The clinical status of patients was assessed at weeks 2 and 6 of the therapeutic regimen. Results. A comparative analysis of treatment efficacy indicated significant differences between therapy groups across various psychometric scales (p&lt;0.05). The co-administration of clozapine with cariprazine, and to a lesser extent with lurasidone, demonstrated the most pronounced therapeutic effect within a 42-day treatment period (p&lt;0.05), specifically in alleviating psychotic symptoms and reducing the negative symptoms characteristic of schizophrenia, as compared to alternative combinations, thereby extending the duration of outpatient treatment. Conclusions. A comprehensive treatment strategy for therapeutically resistant schizophrenia, irrespective of concomitant addictions, is the combination of clozapine with cariprazine; lurasidone serves as an alternative option. The selection of an effective adjunctive therapy should consider the specific type of addiction: lurasidone or aripiprazole is recommended for cannabinoid, psychostimulant, and alcohol dependencies; risperidone or olanzapine is advised for opioid and alcohol dependencies. The combination with brexpiprazole is deemed ineffective. Notable advantages of this approach include a marked effect on negative symptoms and an extension of the outpatient treatment period. No adverse events associated with the combination therapy were reported.<\/jats:p>","DOI":"10.17116\/jnevro2026126091114","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T13:48:20Z","timestamp":1792504100000},"page":"114","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and tolerability of co-administration of clozapine with atypical antipsychotics in patients with treatment-resistant schizophrenia, comorbid with chemical addictions"],"prefix":"10.17116","volume":"126","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8555-3987","authenticated-orcid":false,"given":"G.Yu.","family":"Selivanov","sequence":"first","affiliation":[{"name":"Mental Health Research Institute \u2014 Tomsk National Research Medical Center Russian Academy of Sciences","place":["Tomsk, Russia"]},{"name":"Almazov National Medical Research Center","place":["St. Petersburg, Russia"]},{"name":"Saint Petersburg University of State Fire Service of Emercom of Russia","place":["St. Petersburg, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1052-855X","authenticated-orcid":false,"given":"N.A.","family":"Bokhan","sequence":"additional","affiliation":[{"name":"Mental Health Research Institute \u2014 Tomsk National Research Medical Center Russian Academy of Sciences","place":["Tomsk, Russia"]},{"name":"Siberian State Medical University","place":["Tomsk, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9455-0358","authenticated-orcid":false,"given":"T.V.","family":"Shushpanova","sequence":"additional","affiliation":[{"name":"Mental Health Research Institute \u2014 Tomsk National Research Medical Center Russian Academy of Sciences","place":["Tomsk, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7097-7779","authenticated-orcid":false,"given":"A.A.","family":"Salnikov","sequence":"additional","affiliation":[{"name":"Noyabrsk Psychoneurological Dispensary","place":["Noyabrsk, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7777-5918","authenticated-orcid":false,"given":"K.A.","family":"Blonsky","sequence":"additional","affiliation":[{"name":"Nizhnevartovsk Psychoneurological Hospital","place":["Nizhnevartovsk, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5490-4898","authenticated-orcid":false,"given":"A.P.","family":"Otmakhov","sequence":"additional","affiliation":[{"name":"Almazov National Medical Research Center","place":["St. Petersburg, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6743","reference":[{"key":"key-10.17116\/jnevro2026126091114-1","doi-asserted-by":"publisher","DOI":"10.21265\/PSYPH.2023.11.37.002"},{"key":"key-10.17116\/jnevro2026126091114-2","doi-asserted-by":"publisher","DOI":"10.17116\/jnevro202412407141"},{"key":"key-10.17116\/jnevro2026126091114-3","doi-asserted-by":"publisher","DOI":"10.31684\/25418475-2024-4-5"},{"key":"key-10.17116\/jnevro2026126091114-4","doi-asserted-by":"publisher","DOI":"10.30629\/2618-6667-2023-21-3-6-19"},{"key":"key-10.17116\/jnevro2026126091114-5","doi-asserted-by":"publisher","DOI":"10.30629\/2618-6667-2025-23-2-110-121"},{"key":"key-10.17116\/jnevro2026126091114-6","doi-asserted-by":"publisher","DOI":"10.1007\/s40429-024-00564-0"},{"key":"key-10.17116\/jnevro2026126091114-7","doi-asserted-by":"publisher","DOI":"10.26617\/1810-3111-2024-2(123)-49-64"},{"key":"key-10.17116\/jnevro2026126091114-8","doi-asserted-by":"publisher","DOI":"10.3390\/psychoactives3020013"},{"key":"key-10.17116\/jnevro2026126091114-9","unstructured":"Selivanov GYu, Bokhan NA, Shushpanova OV, et al. Cariprazine in outpatient therapy of schizophrenia comorbid with chemical addictions. Current Therapy of Mental Disorders. 2024;4:43-53. (In Russ.)"},{"key":"key-10.17116\/jnevro2026126091114-10","doi-asserted-by":"publisher","DOI":"10.3390\/ph17040535"},{"key":"key-10.17116\/jnevro2026126091114-11","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0000000000000582"},{"key":"key-10.17116\/jnevro2026126091114-12","doi-asserted-by":"publisher","DOI":"10.30629\/2618-6667-2024-22-4-115-128"},{"key":"key-10.17116\/jnevro2026126091114-13","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyaf053"},{"key":"key-10.17116\/jnevro2026126091114-14","doi-asserted-by":"publisher","DOI":"10.14288\/1.0444808"},{"key":"key-10.17116\/jnevro2026126091114-15","unstructured":"Mosolov SN, Tsukarzi EE, Kapiletti SG. Antipsikhoticheskaya farmakoterapiya shizofrenii: ot nauchnykh dannykh k klinicheskim rekomendatsiyam. Biological methods of treating mental disorders: Evidence-based medicine for clinical practice. M.: Socio-political thought. 2012;11-61. (In Russ.). ISBN: 978-5-915790-75-8"},{"key":"key-10.17116\/jnevro2026126091114-16","unstructured":"Tumova MA, Sosin DN, Ivanov MV, et al. Primenenie farmakogeneticheskikh biomarkerov dlya profilaktiki terapevticheskoy rezistentnosti pri shizofrenii: metodicheskie rekomendatsii. St.P.: V.M. Bekhterev NRMC for psychiatry and neurology. 2020;12. (In Russ.). ISBN: 978-5-94651-067-7"},{"key":"key-10.17116\/jnevro2026126091114-17","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1982.04290070025006"},{"key":"key-10.17116\/jnevro2026126091114-18","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/13.2.261"},{"key":"key-10.17116\/jnevro2026126091114-19","unstructured":"Busner J, Targum SD. The clinical global impressions scale: applying a research tool in clinical practice. Psychiatry (Edgmont). 2007;4(7):28-37"},{"key":"key-10.17116\/jnevro2026126091114-20","doi-asserted-by":"crossref","unstructured":"Endicott J, Spitzer RL, Fleiss JL, et al. The global assessment scale: A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry. 1976;33:766-771","DOI":"10.1001\/archpsyc.1976.01770060086012"},{"key":"key-10.17116\/jnevro2026126091114-21","unstructured":"Schizophrenia. Clinical guidelines. Adults. Electronic publication. Ministry of Health of the Russian Federation. M. 2024;217. (In Russ.). https:\/\/cr.minzdrav.gov.ru\/preview-cr\/451_3"},{"key":"key-10.17116\/jnevro2026126091114-22","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2023.09.027"},{"key":"key-10.17116\/jnevro2026126091114-23","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1321112"},{"key":"key-10.17116\/jnevro2026126091114-24","doi-asserted-by":"publisher","DOI":"10.48612\/psyph\/t6rp-v3zd-hvp5"},{"key":"key-10.17116\/jnevro2026126091114-25","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2025.116670"}],"container-title":["S.S. Korsakov Journal of Neurology and Psychiatry"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T13:48:59Z","timestamp":1792504139000},"score":1,"resource":{"primary":{"URL":"https:\/\/mediasphera.ru\/issues\/zhurnal-nevrologii-i-psikhiatrii-im-s-s-korsakova\/2026\/9\/1199772982026091114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,20]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,10,20]]}},"alternative-id":["10.17116\/jnevro2026126091114"],"URL":"https:\/\/doi.org\/10.17116\/jnevro2026126091114","relation":{},"ISSN":["1997-7298"],"issn-type":[{"value":"1997-7298","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10,20]]}}}